Biosyent Stock Today
| RX Stock | CAD 7.86 0.04 0.51% |
|
|
Biosyent is selling for under 7.86 as of the 3rd of October 2023; that is 0.51% increase since the beginning of the trading day. The stock's lowest day price was 7.8. Biosyent has a very small chance of experiencing financial distress in the next few years but had a somewhat insignificant performance during the last 90 days. Equity ratings for Biosyent are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 4th of August 2023 and ending today, the 3rd of October 2023. Click here to learn more.
Business Domain Pharmaceuticals, Biotechnology & Life Sciences | Category Healthcare | Classification Health Care |
BioSyent Inc., a specialty pharmaceutical company, sources, acquires or in-licenses, develops, and sells various pharmaceutical and other healthcare products in Canada and internationally. The company was formerly known as Hedley Technologies Inc. and changed its name to BioSyent Inc. The company has 11.82 M outstanding shares of which 3.8 K shares are at this time shorted by private and institutional investors with about 1.17 trading days to cover. More on Biosyent
Moving together with Biosyent Stock
Moving against Biosyent Stock
Follow Valuation Odds of Bankruptcy
Check how we calculate scores
Biosyent Stock Highlights
Most reasonable investors view market volatility as an opportunity to invest at a favorable price or to sell short against a bearish trend. Biosyent's investment highlights are automatically generated signals that are significant enough to either complement your investing judgment regarding Biosyent or challenge it. These highlights can help you better understand the position you are entering and avoid costly mistakes.
| Chairman | Rene Goehrum |
| Macroaxis Advice The buy hold or sell recommendation is provided in the context of your current investment horizon and risk tolerance. The advice algorithm takes into account all of Biosyent's available fundamental, technical, and predictive indicators. Your current horizon is 90 days - details Strong BuyUndervalued | |
Biosyent (RX) is traded on TSX Venture Exchange in Canada and employs 15 people. Biosyent is listed under Pharmaceuticals category by Fama And French industry classification. The company currently falls under 'Micro-Cap' category with a current market capitalization of 92.44 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Biosyent's market, we take the total number of its shares issued and multiply it by Biosyent's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. Biosyent conducts business under Pharmaceuticals sector and is part of Health Care industry. The entity has 11.82 M outstanding shares of which 3.8 K shares are at this time shorted by private and institutional investors with about 1.17 trading days to cover.
Biosyent currently holds about 22.46 M in cash with 4.95 M of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 1.59.
Check Biosyent Probability Of Bankruptcy
OwnershipBiosyent retains a total of 11.82 Million outstanding shares. Biosyent retains significant amount of outstanding shares owned by insiders. An insider is usually defined as a CEO, other corporate executive, director, or institutional investor who own at least 10% of the company's outstanding shares. Since such a large part of the company is owned by insiders, it is advisable to analyze if each of these insiders have been buying or selling the stock in recent months. Note that regardless of who owns the company, if the true value of the entity is less than the market is willing to pay for it, you may not be able to generate positive returns over time.
Ownership Allocation
Check Biosyent Ownership DetailsBiosyent Stock Price Odds Analysis
Depending on a normal probability distribution, the odds of Biosyent jumping above the current price in 90 days from now is about 22.36%. The Biosyent probability density function shows the probability of Biosyent stock to fall within a particular range of prices over 90 days. Given the investment horizon of 90 days Biosyent has a beta of 0.3524 indicating as returns on the market go up, Biosyent average returns are expected to increase less than the benchmark. However, during the bear market, the loss on holding Biosyent will be expected to be much smaller as well. Additionally, the company has an alpha of 0.1205, implying that it can generate a 0.12 percent excess return over NYSE Composite after adjusting for the inherited market risk (beta).
Based on a normal probability distribution, the odds of Biosyent to move above the current price in 90 days from now is about 22.36 (This Biosyent probability density function shows the probability of Biosyent Stock to fall within a particular range of prices over 90 days) .
Biosyent Risk Profiles
Investors will always prefer to have the highest possible return on investment while minimizing volatility. Biosyent market risk premium is the additional return an investor will receive from holding Biosyent long position in a well-diversified portfolio. The market premium is part of the Capital Asset Pricing Model (CAPM), which most analysts and investors use to calculate the acceptable rate of return on investment in Biosyent. At the center of the CAPM is the concept of risk and reward, which is usually communicated by investors using alpha and beta measures. Although Biosyent's alpha and beta are two of the key measurements used to evaluate Biosyent's performance over the market, the standard measures of volatility play an important role as well.
| Mean Deviation | 0.94 | |||
| Semi Deviation | 1.32 | |||
| Standard Deviation | 1.57 | |||
| Variance | 2.46 |
Biosyent Stock Against Markets
Picking the right benchmark for Biosyent stock is fundamental to making educated investment choices. Many naive investors compare their positions with the S&P 500 or with the Nasdaq. But these benchmarks are not all-inclusive and generally should be used only for large-capitalization equities or stock offerings from large companies. When the price of a selected benchmark declines in a down market, there may be an uptick in Biosyent stock price where buyers come in believing the asset is cheap. The opposite is true when the market is bullish; so, accurately picking the benchmark for Biosyent is critical whether you are bullish or bearish towards Biosyent at a given time. Please also check how Biosyent's historical prices are related to one of the top price index indicators.
Be your own money manager
Our tools can tell you how much better you can do entering a position in Biosyent without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Correlation Analysis Now
Correlation AnalysisReduce portfolio risk simply by holding instruments which are not perfectly correlated |
| All Next | Launch Module |
Biosyent Corporate Directors
Biosyent corporate directors refer to members of a Biosyent board of directors. The board of directors generally takes responsibility for the Biosyent's affairs and long-term direction of the entity. A corporate director does not make decisions for the corporation on his own. As a member of the board of directors, she or he must function as a part of a group that makes decisions on behalf of the business only by the board of directors' meetings. To pass a resolution, a majority of Biosyent's board members must vote for the resolution. The Biosyent board of directors' duties also include the election, removal, and supervision of officers, including the adoption, amendment, and repeal of bylaws.| Paul Montador | Independent Director | Profile | |
| Joseph Arcuri | Director | Profile | |
| Peter Lockhard | Independent Director | Profile | |
| Milton Wakefield | Independent Director | Profile |
How to buy Biosyent Stock?
Before investing in Biosyent, you must ensure you fully understand your financial goals and how diversified (or not) your overall investments are now. Then, after you clearly understand your investment objectives, consider investing in Biosyent. To buy Biosyent stock, you can follow these steps:- Choose a brokerage firm: You need to select a brokerage firm to buy shares of Biosyent. Some popular options include Charles Schwab, Fidelity, TD Ameritrade, and Robinhood.
- Open an account: Once you have chosen a brokerage firm, you will need to open an account. You will be required to provide personal information, such as your name, address, and Social Security number.
- Fund your account: You will need to deposit funds into your brokerage account to purchase Biosyent stock. You can do this by transferring funds from your bank account or other investment accounts.
- Place your order: Once you have located Biosyent stock in your brokerage account, you can place your order to buy it. You will need to specify the number of shares you want to buy and the price you are willing to pay.
- Monitor your investment: After you have purchased Biosyent stock, you should monitor your investment to track its performance and make informed decisions about buying, selling, or holding the stock
It's important to note that investing in stocks, such as Biosyent, carries risks, and you should carefully consider your investment goals and risk tolerance before making any investment decisions. Also, remember various factors, including economic indicators, change in net worth, political events, company-specific news, and investor sentiment, can influence the stock market. These factors can cause fluctuations in stock prices and lead to market volatility affecting your buy or sell decision. However, volatility can also present opportunities for investors to make gains by buying stocks when prices are low and selling when they are high. It's important for investors to have a long-term perspective and a well-diversified portfolio to manage the impact of stock market volatility on their investments.
Already Invested in Biosyent?
The danger of trading Biosyent is mainly related to its market volatility and company specific events. As an investor, you must understand the concept of risk-adjusted return before you start trading. The most common way to measure the risk of Biosyent is by using the Sharpe ratio. The ratio expresses how much excess return you acquire for the extra volatility you endure for holding a more risker asset than Biosyent. The Shape ratio is calculated by using standard deviation and excess return to determine reward per unit of risk. To understand how volatile Biosyent is, you must compare it to a benchmark. Traditionally, the risk-free rate of return is the rate of return on the shortest-dated U.S. Treasury, such as a 3-year bond.
Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Biosyent. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in persons. You can also try the Crypto Correlations module to use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins.
Complementary Tools for Biosyent Stock analysis
When running Biosyent's price analysis, check to measure Biosyent's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Biosyent is operating at the current time. Most of Biosyent's value examination focuses on studying past and present price action to predict the probability of Biosyent's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Biosyent's price. Additionally, you may evaluate how the addition of Biosyent to your portfolios can decrease your overall portfolio volatility.
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
| Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
| Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. | |
| Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
| Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
| Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
| Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
| Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. |